Antimicrobial management of surgically treated gangrenous or perforated appendicitis: Comparison of cefoxitin and clindamycin-gentamicin

Kenneth R Sirinek, B. A. Levine

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Patients with gangrenous or perforated appendicitis were treated with cefoxitin or a combination of clindamycin and gentamicin for a minimum of five post-operative days. Septic complications developed in four of the 54 patients receiving cefoxitin: one was an intra-abdominal abscess requiring surgery and three were wound infections. Of the 51 patients receiving clindamycin-gentamicin, two had septic complications: one was an intra-abdominal abscess requiring surgery and one was a wound abscess requiring drainage. The differences in the septic complications in the two treatment groups were not statistically significant. The cost to the patient of combined therapy with clindamycin and gentamicin was 36% higher than the cost of cefoxitin alone. The results demonstrate that cefoxitin alone is comparable to the 'gold standard' of clindamycin-gentamicin in the treatment of patients with gangrenous or perforated appendicitis.

Original languageEnglish (US)
Pages (from-to)420-428
Number of pages9
JournalClinical Therapeutics
Volume9
Issue number4
StatePublished - 1987

Fingerprint

Cefoxitin
Clindamycin
Appendicitis
Gentamicins
Abdominal Abscess
Costs and Cost Analysis
Wound Infection
Abscess
Drainage
Therapeutics
Wounds and Injuries

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{eaef997f6d7848ae98ee699bb46b910c,
title = "Antimicrobial management of surgically treated gangrenous or perforated appendicitis: Comparison of cefoxitin and clindamycin-gentamicin",
abstract = "Patients with gangrenous or perforated appendicitis were treated with cefoxitin or a combination of clindamycin and gentamicin for a minimum of five post-operative days. Septic complications developed in four of the 54 patients receiving cefoxitin: one was an intra-abdominal abscess requiring surgery and three were wound infections. Of the 51 patients receiving clindamycin-gentamicin, two had septic complications: one was an intra-abdominal abscess requiring surgery and one was a wound abscess requiring drainage. The differences in the septic complications in the two treatment groups were not statistically significant. The cost to the patient of combined therapy with clindamycin and gentamicin was 36{\%} higher than the cost of cefoxitin alone. The results demonstrate that cefoxitin alone is comparable to the 'gold standard' of clindamycin-gentamicin in the treatment of patients with gangrenous or perforated appendicitis.",
author = "Sirinek, {Kenneth R} and Levine, {B. A.}",
year = "1987",
language = "English (US)",
volume = "9",
pages = "420--428",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Antimicrobial management of surgically treated gangrenous or perforated appendicitis

T2 - Comparison of cefoxitin and clindamycin-gentamicin

AU - Sirinek, Kenneth R

AU - Levine, B. A.

PY - 1987

Y1 - 1987

N2 - Patients with gangrenous or perforated appendicitis were treated with cefoxitin or a combination of clindamycin and gentamicin for a minimum of five post-operative days. Septic complications developed in four of the 54 patients receiving cefoxitin: one was an intra-abdominal abscess requiring surgery and three were wound infections. Of the 51 patients receiving clindamycin-gentamicin, two had septic complications: one was an intra-abdominal abscess requiring surgery and one was a wound abscess requiring drainage. The differences in the septic complications in the two treatment groups were not statistically significant. The cost to the patient of combined therapy with clindamycin and gentamicin was 36% higher than the cost of cefoxitin alone. The results demonstrate that cefoxitin alone is comparable to the 'gold standard' of clindamycin-gentamicin in the treatment of patients with gangrenous or perforated appendicitis.

AB - Patients with gangrenous or perforated appendicitis were treated with cefoxitin or a combination of clindamycin and gentamicin for a minimum of five post-operative days. Septic complications developed in four of the 54 patients receiving cefoxitin: one was an intra-abdominal abscess requiring surgery and three were wound infections. Of the 51 patients receiving clindamycin-gentamicin, two had septic complications: one was an intra-abdominal abscess requiring surgery and one was a wound abscess requiring drainage. The differences in the septic complications in the two treatment groups were not statistically significant. The cost to the patient of combined therapy with clindamycin and gentamicin was 36% higher than the cost of cefoxitin alone. The results demonstrate that cefoxitin alone is comparable to the 'gold standard' of clindamycin-gentamicin in the treatment of patients with gangrenous or perforated appendicitis.

UR - http://www.scopus.com/inward/record.url?scp=0023217848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023217848&partnerID=8YFLogxK

M3 - Article

C2 - 3607822

AN - SCOPUS:0023217848

VL - 9

SP - 420

EP - 428

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 4

ER -